Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.63T | 1.32T | 1.35T | 1.17T | 1.11T |
Gross Profit | 374.51B | 144.85B | 282.00B | 209.41B | 179.97B |
EBITDA | 224.01B | 8.84B | 149.11B | 175.27B | 114.47B |
Net Income | 112.74B | -68.21B | 44.55B | 66.06B | 13.09B |
Balance Sheet | |||||
Total Assets | 2.24T | 2.10T | 1.94T | 1.88T | 1.83T |
Cash, Cash Equivalents and Short-Term Investments | 136.81B | 142.56B | 129.12B | 148.68B | 122.16B |
Total Debt | 514.72B | 574.38B | 519.49B | 505.55B | 605.93B |
Total Liabilities | 1.73T | 1.70T | 1.49T | 1.47T | 1.51T |
Stockholders Equity | 481.73B | 375.99B | 431.25B | 382.13B | 300.77B |
Cash Flow | |||||
Free Cash Flow | 117.39B | 1.12B | -8.46B | 68.58B | -21.08B |
Operating Cash Flow | 177.63B | 62.12B | 54.12B | 114.16B | 36.38B |
Investing Cash Flow | -58.59B | -51.70B | -52.35B | 27.93B | -40.48B |
Financing Cash Flow | -116.45B | -2.57B | -24.04B | -121.49B | -23.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | $10.77B | 15.80 | 5.51% | 1.90% | 3.03% | -26.66% | |
64 Neutral | ¥2.22T | 19.74 | 25.94% | 0.95% | 23.00% | ― | |
$9.72B | 18.99 | 19.46% | 1.68% | ― | ― | ||
$8.68B | 16.25 | 16.07% | 2.20% | ― | ― | ||
$11.72B | 20.80 | 12.94% | 1.49% | ― | ― | ||
$21.75B | 19.69 | 9.86% | 1.42% | ― | ― | ||
$2.61B | 1,039.02 | 0.06% | 0.03% | ― | ― |
IHI Corporation has announced its consideration of reducing its investment unit to enhance stock liquidity and attract a broader range of investors. The company plans to evaluate this move by examining stock price trends and associated implementation costs, which could impact its market positioning and investor engagement.
The most recent analyst rating on (JP:7013) stock is a Buy with a Yen13800.00 price target. To see the full list of analyst forecasts on IHI stock, see the JP:7013 Stock Forecast page.
IHI Corporation announced the introduction of a Restricted Stock Remuneration Plan for its directors, aimed at encouraging shareholding and aligning directors’ interests with those of shareholders. This plan, separate from the existing Performance-Linked Stock Remuneration, is designed to enhance medium- to long-term corporate value and performance, with implications for improved stakeholder engagement and corporate governance.
The most recent analyst rating on (JP:7013) stock is a Buy with a Yen13800.00 price target. To see the full list of analyst forecasts on IHI stock, see the JP:7013 Stock Forecast page.
IHI Corporation reported significant financial improvement for the fiscal year ended March 31, 2025, with a 23% increase in revenue and a return to profitability. This positive performance reflects a strong recovery from the previous fiscal year’s losses, enhancing the company’s market position and potentially benefiting stakeholders.
IHI Corporation has reported foreign exchange losses amounting to 16.5 billion yen for the three months ending March 31, 2025, contributing to a total of 6.6 billion yen in losses for the fiscal year. These financial costs have been incorporated into the company’s consolidated financial performance, potentially affecting its financial stability and market perception.
IHI Corporation has announced the nomination of Ms. Yayoi Tanaka as an independent director, aiming to enhance its corporate governance. Ms. Tanaka’s extensive experience in fiscal oversight and corporate governance, including her previous role as an independent director at IHI, positions her to contribute significantly to the company’s management and value enhancement.